Daniel Wolterman Joins Invuity’s Board of Directors
August 30 2017 - 8:00AM
Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company
focused on minimal access surgery, announced today that healthcare
industry leader Daniel Wolterman has been appointed to its Board of
Directors, effective September 5, 2017. Wolterman was most recently
President & Chief Executive Officer of Memorial Herman
Healthcare System.
"We are pleased to welcome Dan to Invuity’s Board of Directors,"
said Invuity Chief Executive Officer Philip Sawyer. "His
significant insight into healthcare systems will be extremely
valuable as we continue to grow our business by providing
innovative product solutions to our hospital customers."
Wolterman joined Memorial Hermann Healthcare System in May 1999.
He was named Chief Executive Officer in November 2002 and retired
in August 2016. Under Wolterman’s leadership, Memorial Hermann
became one of the largest healthcare systems in Texas, operating in
16 hospitals and over 232 ancillary locations with 24,000 employees
and is now the country’s busiest Level 1 trauma center and
generating $6.0 billion in net revenue. Prior to Memorial Hermann,
Wolterman was Senior Vice President, Operations & Business
Development at Sisters of Charity of the Incarnate Word Health Care
System from 1993 to 1999 and President & CEO of Holy Cross
Health Services of Utah from 1989 to 1993. Wolterman
currently serves on the Boards of Directors of Nuvasive
(Nasdaq:NUVA), Vizient, Inc. and Legacy ER & Urgent Care.
"I'm excited about the opportunity to work with the
management team and board to assist Invuity in realizing
its significant potential," said Wolterman. "The company’s
proprietary technologies and innovative product solutions provide a
meaningful clinical benefit to physicians, patients and health
care systems.”
About Invuity®
Invuity, Inc. is a leading medical technology company focused on
developing and marketing advanced surgical devices to improve the
ability of physicians to perform minimal access surgery through
smaller and hidden incisions. The company's patented Intelligent
Photonics™ technology delivers enhanced visualization which
facilitates surgical precision, efficiency and safety. In addition,
the company utilizes comprehensive strategic marketing programs to
create stronger institutional partnerships. Clinical applications
include women’s health, encompassing breast cancer and breast
reconstruction surgery, gynecology and thyroid surgery.
Additional applications include procedures for electrophysiology,
spine, orthopedic, cardiothoracic, and general surgery. Invuity is
headquartered in San Francisco, CA. For more information, visit
www.invuity.com.
CONTACT:
Company Contact:
Jim Mackaness
Chief Financial Officer
Invuity, Inc.
415-655-2129
Investors:
Mark Klausner
Westwicke Partners
443-213-0501
irdept@invuity.com
INVUITY, INC. (NASDAQ:IVTY)
Historical Stock Chart
From Jun 2024 to Jul 2024
INVUITY, INC. (NASDAQ:IVTY)
Historical Stock Chart
From Jul 2023 to Jul 2024